【TOPGLOV 7113 交流专区】顶级手套

东邪

7113

Notice of Shares Buy Back - Immediate Announcement

Date of Buy Back : 28/01/2008 Description of Shares Purchased : Ordinary Shares of RM0.50 No. of Shares Purchased : 35,000 shares Minimum Price Paid For Each Share Purchased : RM 5.300 Maximum Price Paid For Each Share Purchased : RM 5.450 Total Consideration Paid : RM 187,145.00 No. of Shares Purchased Retained in Treasury : 35,000 shares No. of Shares Which Are Proposed To Be Cancelled : shares Cumulative Net Outstanding Treasury Shares As At To-Date : 5,135,000 shares Adjusted Issued Capital After Cancellation : 0 Date Lodged With Registrar of Company : Lodged By : Remarks: N/A Submitted By: Ms. Chua Siew Chuan

28/01/2008   06:05 PM

东邪

7113

Proposed establishment of a new employees’ share option scheme

TOP GLOVE CORPORATION BERHAD (“TOP GLOVE” OR THE “COMPANY”) Proposed establishment of a new employees’ share option scheme (“ESOS”) for eligible employees and Directors of Top Glove and its subsidiaries (“Proposed New ESOS”) We refer to Top Glove’s announcement dated 19 October 2007 in connection with the Proposed New ESOS (“Announcement”). Unless otherwise defined, the definitions set out in the Announcement shall apply herein. On behalf of the Board of Directors of Top Glove, RHB Investment Bank Berhad is pleased to announce that Bursa Malaysia Securities Berhad had vide its letter dated 24 January 2008 granted its approval-in-principle for such number of additional new Top Glove Shares, representing 15% of the issued and paid-up share capital of Top Glove, to be issued pursuant to the exercise of options under the new ESOS. This announcement is dated 28 January 2008. You are advised to read the entire contents of the announcement or attachment. To read the entire contents of the announcement or attachment, please access the Bursa website at http://www.bursamalaysia.com .

28/01/2008   06:56 PM

34350

Notice of Shares Buy Back - Immediate Announcement

Buy Back Date	28 Jan 2008
Shares Purchased Description	Ordinary Shares of RM0.50
Min Price Per Share (RM)	5.300
Max Price Per Share (RM)	5.450
Total Share Purchased (units)	35,000
Total Consideration Paid (RM)	187,145.00
Cumulative Net Outstanding Treasury Shares as At-Date (units)	5,135,000
Number of Shares Purchased Retained in Treasury (units)	35,000

34350

Proposed establishment of a new employees' share option scheme
28 Jan 2008, 18:56
Proposed establishment of a new employees' share option scheme
TOP GLOVE CORPORATION BERHAD ('TOP GLOVE' OR THE 'COMPANY')
Proposed establishment of a new employees' share option scheme ('ESOS') for
eligible employees and Directors of Top Glove and its subsidiaries ('Proposed
New ESOS')
We refer to Top Glove's announcement dated 19 October 2007 in connection with
the Proposed New ESOS ('Announcement'). Unless otherwise defined, the
definitions set out in the Announcement shall apply herein.
On behalf of the Board of Directors of Top Glove, RHB Investment Bank Berhad is
pleased to announce that Bursa Malaysia Securities Berhad had vide its letter
dated 24 January 2008 granted its approval-in-principle for such number of
additional new Top Glove Shares, representing 15% of the issued and paid-up
share capital of Top Glove, to be issued pursuant to the exercise of options
under the new ESOS.
This announcement is dated 28 January 2008.
You are advised to read the entire contents of the announcement or attachment.
To read the entire contents of the announcement or attachment, please access
the Bursa website at http://www.bursamalaysia.com .

东邪

7113

Notice of Shares Buy Back - Immediate Announcement

Date of Buy Back : 29/01/2008 Description of Shares Purchased : Ordinary Shares of RM0.50 No. of Shares Purchased : 24,000 shares Minimum Price Paid For Each Share Purchased : RM 5.300 Maximum Price Paid For Each Share Purchased : RM 5.350 Total Consideration Paid : RM 127,680.00 No. of Shares Purchased Retained in Treasury : 24,000 shares No. of Shares Which Are Proposed To Be Cancelled : shares Cumulative Net Outstanding Treasury Shares As At To-Date : 5,159,000 shares Adjusted Issued Capital After Cancellation : 0 Date Lodged With Registrar of Company : Lodged By : Remarks: N/A Submitted By: Ms. Chua Siew Chuan

29/01/2008   05:47 PM

34350

馬美利差擴大‧馬幣兌美元升破3.24
2008-01-29 18:25
（吉隆坡）國家銀行傾向於利用匯率抑制通貨膨脹，加上馬美兩國利率差距可能進一步拉大，馬幣兌美元今日（週二，29日）一度攀至3.2337，輕易寫下逾10年新高。
國行總裁丹斯里潔蒂昨日指出，國內利率仍處適中水平，他們可以透過“其他途徑”應對通膨。
隔夜政策利率維持3.5%
同時，市場預期美國聯邦儲備局將於今明兩天的議息會議後再度降息，加上國家銀行今日宣佈維持隔夜政策利率（OPR）於3.5%，促使馬幣兌美元今日猛漲。
國貿銀行貨幣交易商阿瓦魯丁認為，依潔蒂談話推測，允許馬幣升值顯然是國行的優先選擇。
“外資因此對於國內股市與債市的興趣濃厚。”
今日馬幣兌美元漲至3.2337後，於下午5時收窄至3.2350。阿瓦魯丁估計，馬幣本週可能收在3.22左右。
馬幣數週內漲2.2%
今年至今，馬幣為日圓以外，升幅最大的熱門亞洲貨幣，在短短數週內上漲2.2%。
市場預期聯儲局再降息0.5%
市場普遍預期，聯儲局將再度降息0.5%，亦有預期降息0.25%者，更有許多分析員預期美國利率將不變。
若美國宣佈降息0.5%，這將是2005年3月以來，大馬利率首次超越美國，屆時將吸引更多外資湧進大馬資金市場。美國基準利率目前也是3.5%。
JP摩根策略師在報告中說，聯儲局繼上週緊急降息0.75%後，本週可能再調低利率。
“總的來說，在10天內降息125個基點，將讓美元兌亞洲貨幣走軟。”
不過，他們認為美國與亞洲經濟體的利率差距擴大，將讓亞洲中央銀行左右為難，夾在美國經濟成長放緩與貨幣因利率差距而升值的兩大壓力之下。

34350

创下10年新高 令吉增值至3.23
二零零八年一月二十九日 下午五时四十一分
（吉隆坡29日讯）马币今早兑美元的汇率增值至10年来之新高，但兑美元以外的其他主要货币却大多趋软。
马币兑美元的汇率开市趋稳至3.2340/2380美元的10新高，午休报3.2350/2380令吉，较昨日闭市之3.2400/2420令吉升值。
交易员说，令吉兑美元再创下脱钩以来的新高，因美国于上周二大幅减息0.75%后或会再度减息，但大马利率却依然保持不变，诱使新的资金流入本地股市和汇市，但促使美元受到压力。
国行总裁洁蒂昨日表示，虽然美国大幅减息去激励该国濒临衰退的经济，但大马将不会跟进，因我国目前的利率处于适中的水平，足于支撑国家经济成长。
美元兑多数主要贷币下跌，因市场预期美国联邦储备局本周三（30日）再减息0.5%的机会率已达90%，因数据显示美国12月新屋销售减少，引发对美经济快将陷入衰退的忧虑。市场人士表示，若本周再减息半巴仙，较欧元区再融资利率低10个基点，对全球投资者而言美元再无吸引力。
今日东京汇市，早市时美元报106.24日圆，低过昨午之106.94日圆及周一纽约市场的106.83日圆。隔夜纽约汇市，美元兑由上周五之1.4673美元趋软至 1.4777美元、兑瑞士法郎由1.0974法郎降至1.0898法郎及兑英镑由1.9813美元贬值至1.9840美元。
此外，中国外汇交易中心今日美元兑人民币中间价报7.2020元，上个交易日中间价为7.1996元。

34350

Notice of Shares Buy Back - Immediate Announcement
Date of buy back                                                                                                 : 29/01/2008
Description of shares purchased                                                                       : Ordinary Shares of RM0.50
Total number of shares purchased (units)                                                         : 24,000
Minimum price paid for each share purchased (RM)                                       : 5.300
Maximum price paid for each share purchased (RM)                                       : 5.350
Total consideration paid (RM)                                                                             : 127,680.00
Number of shares purchased retained in treasury (units)                                 : 24,000
Number of shares purchased which are proposed to be cancelled (units)     : 0
Cumulative net outstanding treasury shares as at to-date (units)                     : 5,159,000

hancom

越跌越低，维持评价，跌势股。

chon

想要请教 hancom 一个问题，假使确定那是一支跌势股，
如果基本面是好的想要买进，是否应该再等一等？

又或者之前被套，但又已经确定那是一支跌势股，
那是否应该 Cut loss？

publicpang

很好的问题。。。。。

一只长时间（多过9-12个月）在底价徘徊的股。。。
或在跌势中。。。

一天他不上龙虎榜。。。你一天也别想碰它。。。
它吃定你。。。。。

hancom

你好！如果股价已经疲弱，形成跌势股就一定走。基本面在技术分析里所占的比重不大。可以说是，以技术为主，基本为辅。

如果你是以基本为主，信心十足，现在的确是反向时机，但是，你真的能越跌越低，越买越高兴？何不等？基本面真的那么好的话就算等多久也是值得。与其买入后心急的等，不如在场外观望，休闲的等。

至于买入后被套怎么办？跌破支撑线就走。这是技术分析必须遵守的第一要诀。技术分析，没有感情，保本第一。如果死守，你就会失去了最宝贵的东西，那就是“机会成本”。

publicpang

不错的见解。。。LION KING....

我对 TOPG的 看法是：

大户在低价等票吃。。。
未来（２００８？，２００９？，２０１０？。。哈哈。。鬼知道。。 ）肯定会大吃４方。。。

chon

我都是这么认为，像我这种小散户，那有可能越跌越买，
越买就越高兴，不如就在场外观望，休闲的等来得适当。

至于买入后被套，没有办法之下，CUT LOSS 保本亦是上策，
不然会失去很多的机会成本。

多谢 hancom 兄弟的指教。

hancom

LION KING？这张图越看越奇怪。。。找一天要把他换了！^^

庄家筑底，没必要陪庄，就像你所说的
未来（２００８？，２００９？，２０１０？。。哈哈。。鬼知道。。 ）

hancom

大家互相学习吧！

Mr.Business

原帖由 publicpang 于 30-1-2008 12:34 AM 发表
不错的见解。。。LION KING....

我对 TOPG的 看法是：

大户在低价等票吃。。。
未来（２００８？，２００９？，２０１０？。。哈哈。。鬼知道。。 ）肯定会大吃４方。。。

小弟同意。

如果公司想制造好消息，宣布把回购股票的钱分给股东，或给红股，那可以刺激买气了，可是公司只是静静的回购股票。。。

我以为当5月到了，新ESOS启动，那时Top Glove的情况就会好些了。。。

Mr.Business

真不是好消息。。。

Malaysia fights to clear the air over latex gloves
       
Published: 2008/01/31

WASHINGTON: Malaysian latex glove makers are fighting bad publicity emerging from the US medical community, particularly the Johns Hopkins Hospital, which recently announced that it was banning the use of latex gloves and other latex medical products on its premises.

The hospital in Baltimore, Maryland, has opted to become "latex-safe" by prohibiting the use of all latex gloves and almost all medical latex products to prevent rare but severe allergic reactions, called anaphylaxis, that could include wheezing, rapid heartbeat and a sudden drop in blood pressure.

While such reactions could be fatal, Johns Hopkins anaesthesiologist Dr Robert Brown - who also chairs its latex task force - conceded that he knew of no fatalities at the hospital.

"We do care about our users and their safety is very important to us. We're not just selling gloves, but we're concerned that the decision of Johns Hopkins to eliminate latex gloves from its hospital is based on outdated data," said Dr Esah Yip, director of the Malaysian Rubber Export Promotion Council (MREPC) here.

She described Johns Hopkins' move as an "overreaction" and "misleading".

Yip has written to the hospital about the new class of safer latex gloves that has seen a decline in incidences of latex sensitisation and allergic reactions.

She has also informed the US media and travels around the country to talk about Malaysia's superior latex gloves.

Yip said that new technology adopted by Malaysian manufacturers since the late 1990s had drastically reduced the presence of residual proteins in latex gloves to less than 50 micrograms per decimeter.

The use of such gloves has been shown by a number of independent hospital studies in the US, Canada and Europe to not only vastly reduce sensitisation and allergic reactions, but, more importantly, that latex-allergic individuals can work alongside their colleagues using these improved latex gloves without suffering any ill effects.

A recent study funded by the US Centers for Disease Control and the National Institute of Occupational Safety and Health found that latex gloves' leakage rate, at 5.6 per cent, was much lower than that of surgical gloves made of nitrides (9.3 per cent) or polychloroprene/neoprene (7.4 per cent).

"Johns Hopkins' decision seems to be out of step with the rest of the country and is based on old data that no longer applies, rather than on data from the new class of low-protein latex gloves available today," said Yip.

"Allergy issues should be overcome, not by banning latex gloves but by adopting the policy of using only low-protein, low-powder, or powder-free latex gloves, while allergic individuals should use quality non-latex gloves, as has already been done in other hospitals in the US, Germany and Finland," she added.

Yip said there was no evidence that anaphylactic shock had ever occurred when the low-protein, low- or powder-free latex gloves had been used.

She also pointed out that Mayo Clinic, a leading US medical institution which recently conducted a study, had found that the use of low-protein latex gloves resulted in savings of US$200,000 (about RM648,000) a year.

More than 3,300 physicians, scientists and researchers as well as 46,000 allied health staff work at Mayo Clinic, which also has facilities in Rochester (Minnesota), Jacksonville (Florida) and Scottsdale/Phoenix (Arizona).

Collectively, the three locations treat more than half a million people each year.

Yip said Johns Hopkins' decision to eliminate latex gloves from its hospital could unnecessarily increase its glove cost by 50 per cent.

"Johns Hopkins is spending precious healthcare dollars to fix something that isn't broken, and hasn't been broken since new manufacturing techniques in the late 1990s and early 2000s revolutionised the way latex gloves is made," she said.

While US imports of latex gloves grow steadily every year, challenges lie ahead for the MREPC as the Harbor Hospital in Baltimore and the Shriners Hospital for Children in Sacramento, California, opt to go latex-free.

In 2006, the US imported 18.4 billion pairs of rubber gloves worth US$1.2 billion (RM3.9 billion). Out of this, 9.2 billion pairs worth about US$0.6 billion (RM1.9 billion) were from Malaysia.

In 2004, the US imported 17.6 billion pairs of gloves worth US$1.03 billion (RM3.3 billion), with 8.6 billion pairs worth about US$0.5 billion (RM1.6 billion) coming from Malaysia, according to the Global Trade Atlas. - Bernama

http://www.btimes.com.my/Current ... /Article/index_html

34350

Notice of Shares Buy Back - Immediate Announcement

Buy Back Date	30 Jan 2008
Shares Purchased Description	Ordinary Shares of RM0.50
Min Price Per Share (RM)	5.300
Max Price Per Share (RM)	5.400
Total Share Purchased (units)	27,000
Total Consideration Paid (RM)	143,810.00
Cumulative Net Outstanding Treasury Shares as At-Date (units)	5,186,000
Number of Shares Purchased Retained in Treasury (units)	27,000

Mr.Business

担心美国的发展，我写email去问Top Glove，而Top Glove也很快的回答我的询问。

我的询问。
I read below news report from Business Times that Johns Hopkins Hospital has banned  the use of latex gloves and other latex medical products on its premises.Johns Hopkins Hospital is widely regarded as one of the world's greatest hospitals, and it has topped U.S. News and World Report's ranking of American hospitals for 17 consecutive years, so Johns Hopkins Hospital's banning of latex gloves really is a bad news for latext glove manufacturer, especially Top Glove.

What actions that Top Glove have taken to counter reactive these development?


Top Glove的回答。
Thanks for highlighting the issue.

Following are our comments:
a) The news is nothing new as the US medical industry has raised the protein allergy issue many years ago. This is aggravated by those competitors in US that ONLY selling NON latex glove. That is why MREPC has appointed Dr Yip in the States to promote and inform the right thing about latex gloves.

b) If it is true, FDA in US will be the first to ban the usage of latex glove in all the US hospitals. As Ms Yip mentioned, the protein level has been reduced significantly.

c) There is environment issue of using nitrile glove as well since it is not bio degradable, unlike latex glove  

d) As for TG, we are producing both type of glove, latex and nitrile glove. As an OEM manufacturer, we will produce based on customers need. If there are more demand for nitrile glove, TG will then produce more of it.

e) The production lines in Malaysia can cater for both type of glove, ie interchangeable. So there is no need of additional capital expenditure

f) US is only 30% of our total sales and TG is actively focusing on other developing countries, such as Latin America, Asian and African countries which growth rate is much higher.

Best regards

The Investor Relation Team

[ 本帖最后由 Mr.Business 于 31-1-2008 04:38 PM 编辑 ]